OMF Science Wednesday – Personalized Medicine

Share on facebook
Share on twitter
Share on email

In honor of last week’s conference at Stanford University on Personalized Medicine, at #OMFScienceWednesday we ask the question: What is personalized health?
Whether you call it personalized medicine, precision health, or P4 medicine, we are talking about a current revolution in the way health and disease are being studied, and the way healthcare is being practiced. This means we are moving away from the one-size-fits-all approach, and towards more tailored therapies that account for individual variations at the clinical and molecular level. This means we are aiming to predict the risk and eventually prevent the onset of disease. This means a data-driven revolution, that uses the cutting-edge molecular technologies we talked about last week and sophisticated big data analysis, to predict the best ways to treat disease and maintain health in each person. This means empowering patients to take a more active role in their own healthcare. This means focusing on turning from reactive (treating disease) to proactive (maintaining wellness).

A personalized health approach to research is especially exciting in ME/CFS because of how complex and variable this disease is across patients. This is why OMF funded the big data study on severely ill patients (https://www.omf.ngo/mecfs-severely-ill-big-data-study/). We already know that different patients respond to different treatments, and personalized health research will help us not only to understand why that is, but to find even better treatments or combinations thereof. This is already starting to happen in cancer, where genome sequence information is used to select the most effective drugs for individual patients.
Much of the research OMF supports takes place at Stanford Medicine. Read more about Stanford Medicine’s commitment to precision health in research, in Dean Lloyd Minor’s Forbes op-ed: http://med.stanford.edu/…/dean-minor-on-precision-health.ht…
Dean Minor kicked off the Personalized Health conference at Stanford University, and Ron Davis spoke there about ME/CFS research on Friday afternoon. See the entire program here: https://app.certain.com/profile/web/index.cfm… and follow the live Twitter feed here: http://twitter.com/hashtag/PH17
Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Choose your top ten ME/CFS research priorities – UK survey launched

Take the survey The ME/CFS Priority Setting Partnership (PSP) is giving you the opportunity to define your top ten priorities for future ME/CFS research. In partnership with the James Lind Alliance, the ME/CFS Priority Setting Partnership is launching their second survey today. The research questions in this survey are based on over 5300 ideas submitted

Read More »

Statement from Forward-ME on NICE Roundtable

After NICE held its roundtable to discuss the new ME/CFS guideline, Forward-ME (which #MEAction UK is a member of) have produced the below statement. Clinician and Patient Support Confirmed for new NICE Guideline on ME/CFS. On Monday, Forward-ME and member charities attended a roundtable to review the new ‘NICE guideline on ME/CFS’ with representatives from

Read More »

Is NIH blowing another opportunity to advance ME/CFS research?

Be sure to attend the telebriefing by the Trans-NIH ME/CFS Working Group this Friday (10/22) at 3PM ET. The National Institutes of Health (NIH) has many questions to answer about its lack of tangible progress or strategic acceleration of medical research for people with ME. Read Our Questions for NIH ME/CFS research opportunity being missed

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top